You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

31 search results for: disease progression

UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?
expert video

UEGW 2024 | WHAT Can Be Used to Monitor Treatment Response in EoE and WHEN?

Gastroenterology
Dr. Milli Gupta emphasizes the need to regularly monitor multiple disease domains when assessing treatment response, not just EoE symptoms.
View more
More Than Eosinophils: A Closer Look at the Pathophysiology of EoE
expert video

More Than Eosinophils: A Closer Look at the Pathophysiology of EoE

Gastroenterology
Join Prof. Kathryn Peterson for an expert review on how different immune cells and inflammatory mediators contribute to the pathogenesis of EoE.
View more
The Role of Biomarkers in Clinical Decision-Making in Atopic Dermatitis
expert video

The Role of Biomarkers in Clinical Decision-Making in Atopic Dermatitis

Dermatology
Dr. Stephan Weidinger talks about the role of biomarkers and their impact on clinical decision-making.
View more
Complex EoE Pathophysiology Beyond Esophageal Eosinophilia
expert video

Complex EoE Pathophysiology Beyond Esophageal Eosinophilia

Gastroenterology
Dr. Jonathan Spergel and Prof. Arjan Bredenoord highlight the importance of different immune cells in type 2 inflammation in EoE.
View more
Interplay of Barrier Dysfunction and Type 2 Inflammation in EoE
expert video

Interplay of Barrier Dysfunction and Type 2 Inflammation in EoE

Gastroenterology
Learn from Prof. Seema Aceves about the interconnectivity of type 2 inflammation and barrier dysfunction in mediating EoE pathophysiology.
View more
Patient Burden in Eosinophilic Esophagitis
expert video

Patient Burden in Eosinophilic Esophagitis

Gastroenterology
Drs. Kathryn Peterson and Ikuo Hirano and Profs. Ingrid Terreehorst and Arjan Bredenoord highlight the impact and burden of EoE on the quality of life of patients.
View more
IL-4 and IL-13: Shared and Unique Roles in Atopic Dermatitis (AD) and Prurigo Nodularis (PN)
expert video

IL-4 and IL-13: Shared and Unique Roles in Atopic Dermatitis (AD) and Prurigo Nodularis (PN)

Dermatology
Highlights from the WCD 2023 ADVENT symposium, exploring the distinctions and shared elements of atopic dermatitis and prurigo nodularis.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

For healthcare professionals in Algeria: Please read the additional Terms of Use.

Sanofi | Regeneron Logo

© 2025 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: Costa RicaChange country/region